Literature DB >> 20041936

The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.

Jill V Butler1, Joyce E Whittington, Anthony J Holland, Catherine J McAllister, Anthony P Goldstone.   

Abstract

AIM: Prader-Willi syndrome (PWS) is a genetic disorder historically characterized by two phenotypic stages. The early phenotype in infants is associated with hypotonia, poor suck, and failure to thrive. In later childhood, PWS is associated with intellectual disability, hyperphagia, as well as growth and sex hormone deficiency. Little is known about the transition between phenotypes. This study investigates the nature of the change in infancy and childhood PWS.
METHOD: Forty-six children (22 females, 24 males; mean age 2 y 9 mo, SD 18.9 mo; range 7 mo-5 y) with genetically confirmed PWS participated. Information was obtained on childhood height and weight, and eating behaviour from case notes and by parental interview.
RESULTS: Weight standard deviation scores (SDS) started to exceed height by the end of the first year. Height SDS appeared to fall from near normal at birth until stabilizing below normal around 2 years. Half of the children whose body mass index (BMI) was higher than normal at interview had food interests greater than that of their peers, and the age at which increased age-appropriate eating was first noted was later than the increase of BMI SDS.
INTERPRETATION: Obesity may develop before the increased interest in food, suggesting underlying physiological factors independent of appetite control may be important.

Entities:  

Mesh:

Year:  2009        PMID: 20041936     DOI: 10.1111/j.1469-8749.2009.03530.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

1.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

2.  Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.

Authors:  Dong-Kyu Jin
Journal:  Korean J Pediatr       Date:  2012-07-17

3.  Methodology matters: IVF versus ICSI and embryonic gene expression.

Authors:  Phillip J Bridges; Myoungkun Jeoung; Heyoung Kim; Jung Ho Kim; Dong Ryul Lee; CheMyong Ko; Doris J Baker
Journal:  Reprod Biomed Online       Date:  2011-05-08       Impact factor: 3.828

4.  Nutritional phases in Prader-Willi syndrome.

Authors:  Jennifer L Miller; Christy H Lynn; Danielle C Driscoll; Anthony P Goldstone; June-Anne Gold; Virginia Kimonis; Elisabeth Dykens; Merlin G Butler; Jonathan J Shuster; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2011-04-04       Impact factor: 2.802

5.  Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.

Authors:  Frederick A Kweh; Jennifer L Miller; Carlos R Sulsona; Clive Wasserfall; Mark Atkinson; Jonathan J Shuster; Anthony P Goldstone; Daniel J Driscoll
Journal:  Am J Med Genet A       Date:  2014-10-29       Impact factor: 2.802

6.  Demographics and medical comorbidities among hospitalized patients with Prader-Willi Syndrome: A National Inpatient Sample analysis.

Authors:  James Luccarelli
Journal:  Am J Med Genet A       Date:  2022-07-15       Impact factor: 2.578

7.  Progression of Obstructive Sleep Apnea Syndrome in Pediatric Patients with Prader-Willi Syndrome.

Authors:  Shi-Bing Wong; Mei-Chen Yang; I-Shiang Tzeng; Wen-Hsin Tsai; Chou-Chin Lan; Li-Ping Tsai
Journal:  Children (Basel)       Date:  2022-06-17

Review 8.  The importance of gene-environment interactions in human obesity.

Authors:  Hudson Reddon; Jean-Louis Guéant; David Meyre
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

9.  Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome.

Authors:  Agnieszka Lecka-Ambroziak; Marta Wysocka-Mincewicz; Katarzyna Doleżal-Ołtarzewska; Agata Zygmunt-Górska; Teresa Żak; Anna Noczyńska; Dorota Birkholz-Walerzak; Renata Stawerska; Maciej Hilczer; Monika Obara-Moszyńska; Barbara Rabska-Pietrzak; Elżbieta Gołębiowska; Adam Dudek; Elżbieta Petriczko; Mieczysław Szalecki
Journal:  Diagnostics (Basel)       Date:  2021-04-28

Review 10.  Ontogenesis of oxytocin pathways in the mammalian brain: late maturation and psychosocial disorders.

Authors:  Valery Grinevich; Michel G Desarménien; Bice Chini; Maithé Tauber; Françoise Muscatelli
Journal:  Front Neuroanat       Date:  2015-01-20       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.